These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 7845029)

  • 1. 2',3'-Dideoxyadenosine killing of TdT-positive cells is due to a trace contaminant.
    Koç Y; McCaffrey R
    Leukemia; 1995 Jan; 9(1):53-7. PubMed ID: 7845029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2',3'-Dideoxyadenosine is selectively toxic for TdT-positive cells.
    Spigelman Z; Duff R; Beardsley GP; Broder S; Cooney D; Landau NR; Mitsuya H; Ullman B; McCaffrey R
    Blood; 1988 Jun; 71(6):1601-8. PubMed ID: 2836001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of apoptosis by cordycepin in ADA-inhibited TdT-positive leukemia cells.
    Koç Y; Urbano AG; Sweeney EB; McCaffrey R
    Leukemia; 1996 Jun; 10(6):1019-24. PubMed ID: 8667637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antileukemic activity and mechanism of action of cordycepin against terminal deoxynucleotidyl transferase-positive (TdT+) leukemic cells.
    Kodama EN; McCaffrey RP; Yusa K; Mitsuya H
    Biochem Pharmacol; 2000 Feb; 59(3):273-81. PubMed ID: 10609556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of altered metabolism in dideoxynucleoside pharmacokinetics. Studies of 2'-beta-fluoro-2',3'-dideoxyinosine and 2'-beta-fluoro-2',3'-dideoxyadenosine in rats.
    Singhal D; Morgan ME; Anderson BD
    Drug Metab Dispos; 1996 Oct; 24(10):1155-61. PubMed ID: 8894519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine-mediated killing of cultured epithelial cancer cells.
    Barry CP; Lind SE
    Cancer Res; 2000 Apr; 60(7):1887-94. PubMed ID: 10766176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isoproterenol antagonistic effect of 2',5'-dideoxyadenosine in the isolated perfused guinea-pig heart.
    Hartmann M; Schrader J
    J Mol Cell Cardiol; 1993 Mar; 25(3):331-8. PubMed ID: 8389889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythroid differentiation and growth inhibition of K562 cells by 2',5'-dideoxyadenosine: synergism with interferon-alpha.
    Ogawa K; Tashima M; Takeda Y; Sawai H; Toi T; Sawada H; Maruyama Y; Okuma M
    Leuk Res; 1995 Oct; 19(10):749-55. PubMed ID: 7500653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the antiviral activity of hydrophobic amino acid phosphoramidate monoesters of 2'3'-dideoxyadenosine (DDA) and 3'-azido-3'-deoxythymidine (AZT).
    Chang SL; Griesgraber G; Wagner CR
    Nucleosides Nucleotides Nucleic Acids; 2001 Aug; 20(8):1571-82. PubMed ID: 11554546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular metabolism of beta-L-2',3'-dideoxyadenosine: relevance to its limited antiviral activity.
    Placidi L; Cretton-Scott E; Gosselin G; Pierra C; Schinazi RF; Imbach JL; el Kouni MH; Sommadossi JP
    Antimicrob Agents Chemother; 2000 Apr; 44(4):853-8. PubMed ID: 10722481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of high-performance liquid chromatography and thermospray high-performance liquid chromatography-mass spectrometry to the analysis and identification of 2',3'-dideoxyadenosine and its metabolite in biological media.
    Blau PA; Hines JW; Voyksner RD
    J Chromatogr; 1987 Sep; 420(1):1-12. PubMed ID: 3499445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of K and NK lymphocyte cytotoxicity by an inhibitor of adenosine deaminase and deoxyadenosine.
    Grever MR; Siaw MF; Coleman MS; Whisler RL; Balcerzak SP
    J Immunol; 1983 Jan; 130(1):365-9. PubMed ID: 6600187
    [No Abstract]   [Full Text] [Related]  

  • 13. cycloSal-Pronucleotides of 2'-fluoro-ara- and 2'-fluoro-ribo-2',3'- dideoxyadenosine as a strategy to bypass a metabolic blockade.
    Meier C; Knispel T; Marquez VE; Siddiqui MA; De Clercq E; Balzarini J
    J Med Chem; 1999 May; 42(9):1615-24. PubMed ID: 10229630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzymatic properties of the unnatural beta-L-enantiomers of 2',3'-dideoxyadenosine and 2',3'-didehydro-2',3'-dideoxyadenosine.
    Pélicano H; Pierra C; Eriksson S; Gosselin G; Imbach JL; Maury G
    J Med Chem; 1997 Nov; 40(24):3969-73. PubMed ID: 9397178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of 2'-deoxycoformycin on the metabolism of purines and the survival of malignant cells in a patient with T-cell leukemia.
    Yu AL; Bakay B; Kung FH; Nyhan WL
    Cancer Res; 1981 Jul; 41(7):2677-82. PubMed ID: 6972800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibacterial activity of 2',3'-dideoxyadenosine in vivo and in vitro.
    Beskid G; Eskin B; Cleeland R; Siebelist J; Cappetta A; Hill AD; Geiger RH
    Antimicrob Agents Chemother; 1981 Mar; 19(3):424-8. PubMed ID: 6972730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disposition of 2',3'-dideoxyadenosine and 2',3'-dideoxyinosine in mice.
    el Dareer SM; Tillery KF; Kalin JR; Hill DL
    Invest New Drugs; 1989 Jul; 7(2-3):139-46. PubMed ID: 2507472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of the anti-HIV-1 activity of ddAdo by coformycin, EHNA and deaza-EHNA derivatives.
    Marongiu ME; Pani A; Tinti E; Grifantini M; Franchetti P; Cristalli G; La Colla P
    New Microbiol; 1995 Oct; 18(4):359-70. PubMed ID: 8590388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two approaches that increase the activity of analogs of adenine nucleosides in animal cells.
    Plunkett W; Cohen SS
    Cancer Res; 1975 Jun; 35(6):1547-54. PubMed ID: 1079475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphoramidate derivatives of 2',5'-dideoxyadenosine as potential inhibitors of the EDHF phenomenon.
    Gavazza F; Daverio F; Chaytor AT; Griffith TM; McGuigan C
    Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):553-5. PubMed ID: 16247988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.